Detalhe da pesquisa
1.
Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonists.
Br J Clin Pharmacol
; 90(2): 392-405, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653680
2.
Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Hum Reprod
; 37(5): 884-894, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143669
3.
Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding.
Lancet
; 400(10356): 866-867, 2022 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36116467
4.
Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?
J Minim Invasive Gynecol
; 22(7): 1153-62, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26151760
5.
The effect of transcervical resection of submucous fibroids on menstrual blood loss: A prospective cohort study.
Eur J Obstet Gynecol Reprod Biol
; 274: 128-135, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640441
6.
Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study.
BMJ Open
; 11(11): e052664, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815284
7.
Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study.
Res Pract Thromb Haemost
; 5(1): 223-230, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33537547
8.
Hypertension risk in Dutch women with symptomatic uterine fibroids.
Am J Hypertens
; 28(4): 487-92, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25241046